PetaGene, the Cambridge, UK-based leaders in genomic data compression today announced that they have become a NetApp Alliance Partner. Combining PetaGene’s expertise in compression techniques specifically designed for genomic data with NetApp’s...
Read moreMedicinal Genomics Corp. (MGC), a pioneer in using genomics to improve the quality, quantity and safety of cannabis, announced the initiation of a cannabis pan-genome project, a comparative genetic analysis of several different cannabis cultivars...
Read moreHitgen Inc., announced today that it has achieved a milestone in its discovery alliance with Merck & Co. Inc., Kenilworth NJ, USA, known as MSD outside the United States and Canada. The milestone was for the identification of candidates...
Read moreRealbio Technology (RBT), a Shanghai genomic screening company, raised $15 million in a Series A+ funding. The company has a dual focus on colorectal and microbiome screening. RBT operates in three areas: REALGENE provides scientific research...
Read moreCrop Infrastructure Corp. (CSE: CROP) (OTC: CRXPF) (Frankfurt: 2FR) announced today that it has identified multiple Tenants for a roll out strategy to enter Oklahoma to target the Medical Cannabis market focusing on Cultivation, Extraction and...
Read moreI-Mab Biopharma of Shanghai formed a process development partnership with WuXi Biologics to use WuXi Bio’s expertise for CMC development of at least five programs and commercial manufacturing of at least one program for its proprietary...
Read moreJF Intelligent Healthcare Technology of Nanchang raised $5 million from GreyBird Ventures, a US firm, to support its efforts to develop intelligent technologies for better diagnoses at China community healthcare providers in tier three and four...
Read moreCASI, a US in-licensing pharma with operations in China, acquired global rights to an investigational anti-CD38 immunotherapy from Black Belt Therapeutics of the UK. CASI made a $5.5 million upfront payment and invested $2.2 million in Black...
Read moreClick here to find more details This is NAI’s new China News Weekly. We will be covering the latest Chinese foreign investment trends every week. To continue to receive our China News Weekly, please click Here to subscribe.
Read moreCanopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) is pleased to announce that it has completed an all-cash acquisition of Spain-based licensed cannabis producer Cáñamo y Fibras Naturales...
Read moreServier Pharma (Tianjin) signed a strategic cooperation agreement with Mitsubishi Tanabe Pharma to promote Mitsubishi’s type 2 diabetes treatment drug Tenelia® (teneligliptin), a DPP-4 inhibitor, in mainland China. MTPC has completed the...
Read moreFirst Conditionally Active Biologics licensing participation in Greater China territory BioAtla ®, LLC, a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) protein therapeutics for the...
Read more
